ERBB2 and cancer: To determine whether the mammary EMT signature associates with specific breast cancer subtypes, we analyzed the expression of the 265-gene mammary EMT signature in 48 breast cancer cell lines from the Cancer Cell Line Encyclopedia (CCLE) that classifies the cell lines as luminal, basal A, basal B, or HER2-enriched (49).